Skip to content

Effects of IV Chloride Content on Outcomes

A Comparison of High and Low Chloride Containing IV Fluid Solutions in Patients Undergoing Major Surgery and/or ICU Admission

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02083198
Enrollment
1558
Registered
2014-03-11
Start date
2013-09-30
Completion date
2014-04-01
Last updated
2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Balanced Fluids, Plasmalyte, SIRS

Keywords

hyperchloremic acidosis, balanced fluids, plasmalyte

Brief summary

This observational study evaluates the impact of high and low chloride containing IV fluids on administrative and clinical outcomes. The study uses a large electronic health dataset and examines patients receiving fluid replacement and resuscitation. The hypothesis is that high chloride solutions are associated with adverse outcomes as measured by administrative data and by clinical parameters.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults meeting SIRS criteria receiving at least 500 mL of fluid replacement on day of SIRS.

Exclusion criteria

* Receipt of starches or other colloids

Design outcomes

Primary

MeasureTime frameDescription
MortalityHospitalization, Expected Length of inpatient stay is approximately 7 daysInpatient mortality. Expected Length of inpatient stay is approximately 7 days

Secondary

MeasureTime frame
Length of Stayinpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Acute renal failureinpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
dysrhythmiasinpatient hospitalization, Expected Length of inpatient stay is approximately 7 days
Electrolyte disordersinpatient hospitalizationExpected Length of inpatient stay is approximately 7 days
Infectionsinpatient hospitalization, Expected Length of inpatient stay is approximately 7 days

Other

MeasureTime frame
readmission30, 60 and 90 day

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 15, 2026